1. Home
  2. GRC vs EOLS Comparison

GRC vs EOLS Comparison

Compare GRC & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRC
  • EOLS
  • Stock Information
  • Founded
  • GRC 1933
  • EOLS 2012
  • Country
  • GRC United States
  • EOLS United States
  • Employees
  • GRC N/A
  • EOLS N/A
  • Industry
  • GRC Fluid Controls
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRC Industrials
  • EOLS Health Care
  • Exchange
  • GRC Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • GRC 942.4M
  • EOLS 854.0M
  • IPO Year
  • GRC N/A
  • EOLS 2018
  • Fundamental
  • Price
  • GRC $36.18
  • EOLS $12.22
  • Analyst Decision
  • GRC
  • EOLS Strong Buy
  • Analyst Count
  • GRC 0
  • EOLS 4
  • Target Price
  • GRC N/A
  • EOLS $24.67
  • AVG Volume (30 Days)
  • GRC 76.8K
  • EOLS 693.2K
  • Earning Date
  • GRC 04-24-2025
  • EOLS 05-06-2025
  • Dividend Yield
  • GRC 2.05%
  • EOLS N/A
  • EPS Growth
  • GRC 14.58
  • EOLS N/A
  • EPS
  • GRC 1.53
  • EOLS N/A
  • Revenue
  • GRC $659,667,000.00
  • EOLS $266,274,000.00
  • Revenue This Year
  • GRC $4.76
  • EOLS $35.06
  • Revenue Next Year
  • GRC $4.50
  • EOLS $33.04
  • P/E Ratio
  • GRC $23.60
  • EOLS N/A
  • Revenue Growth
  • GRC 0.02
  • EOLS 31.76
  • 52 Week Low
  • GRC $30.47
  • EOLS $9.25
  • 52 Week High
  • GRC $43.79
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • GRC 45.18
  • EOLS 39.01
  • Support Level
  • GRC $34.69
  • EOLS $11.59
  • Resistance Level
  • GRC $36.52
  • EOLS $13.66
  • Average True Range (ATR)
  • GRC 0.84
  • EOLS 0.53
  • MACD
  • GRC -0.06
  • EOLS -0.11
  • Stochastic Oscillator
  • GRC 46.13
  • EOLS 30.43

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: